Dean C. Pavlick

机构：Foundation Medicine (United States) · ORCID：0000-0001-6075-6246

发表论文 265 篇 · 总被引 4868 次 · h-index 33

代表论文

• First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer (2024 · Journal of Clinical Oncology · 被引 20)
• Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 study (2026 · The Lancet Oncology · 被引 15)
• Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study (2025 · ESMO Open · 被引 7)
• Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations (2024 · The Oncologist · 被引 6)
• Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma (2024 · Journal of Translational Medicine · 被引 3)
• Age and Sex Affects the Frequency and Mutation Type of FGFR2 Alterations in Cholangiocarcinoma (2024 · JCO oncology advances. · 被引 3)